These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2740063)

  • 1. First-line chemotherapy of advanced breast cancer with mitoxantrone, cyclophosphamide and vincristine.
    Bezwoda WR; Dansey R; Seymour L
    Oncology; 1989; 46(4):208-11. PubMed ID: 2740063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.
    Bezwoda WR; Seymour L; Dansey RD
    J Clin Oncol; 1995 Oct; 13(10):2483-9. PubMed ID: 7595697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of mitoxantrone-based combination chemotherapy regimens as first-line treatment for advanced breast cancer.
    Bezwoda WR; Hesdorffer CS; Dansey RD
    S Afr Med J; 1987 Oct; 72(7):465-7. PubMed ID: 3660150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced breast cancer: a randomized study of doxorubicin or mitoxantrone in combination with cyclophosphamide and vincristine.
    Green JA; Slater AJ; Campbell IR; Kelly V
    Breast Cancer Res Treat; 1996; 39(2):155-63. PubMed ID: 8872324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancer.
    Ransom DT; Neuberg D; Loprinzi CL; Tormey DC; Blum RH; Harris JE; Asbury RF; Falkson G
    Am J Clin Oncol; 1991 Feb; 14(1):45-8. PubMed ID: 1898999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. A study of short-term response rate.
    Misset JL; Metz R; Gil-Delgado M; Keiling R; Cappelaere P; Armand JP; Prévot G; Grimbert J; Mathé G; Hibberd M
    Anticancer Res; 1987; 7(4B):737-40. PubMed ID: 3674760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone, 5-fluorouracil and cyclophosphamide in advanced breast cancer.
    Martoni A; Rani P; Ercolino L; Canova N; Pannuti F
    Chemioterapia; 1988 Oct; 7(5):345-9. PubMed ID: 3224403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line chemotherapy of advanced breast cancer with a combination of mitoxantrone, methotrexate, and vincristine (MIMO).
    Samonis G; Bafaloukos D; Margioris AN; Katsarma G; Toloudis P; Bacoyannis C; Karvounis N; Georgoulias V; Kosmidis P
    Oncology; 1997; 54(5):371-5. PubMed ID: 9260597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive chemotherapy with cisplatin, mitoxantrone, methotrexate and vincristine in metastatic breast cancer.
    Queirolo P; Repetto L; Gardin G; Miglietta L; Guido T; Pronzato P; Rosso R
    J Chemother; 1991 Jun; 3(3):194-7. PubMed ID: 1919659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
    Smith IE; Powles TJ
    Oncology; 1993 Apr; 50 Suppl 1():9-15. PubMed ID: 8483562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer.
    Bafaloukos D; Samonis G; Klinaki A; Daliani D; Karvounis N; Bacoyiannis C; Karabelis A; Milonakis N; Kosmidis P
    Eur J Cancer; 1993; 29A(6):851-3. PubMed ID: 8484975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
    Unterhalt M; Herrmann R; Tiemann M; Parwaresch R; Stein H; Trümper L; Nahler M; Reuss-Borst M; Tirier C; Neubauer A; Freund M; Kreuser ED; Dietzfelbinger H; Bodenstein H; Engert A; Stauder R; Eimermacher H; Landys K; Hiddemann W
    Leukemia; 1996 May; 10(5):836-43. PubMed ID: 8656680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of combination chemotherapy with mitoxantrone, vincristine, prednisolone (MVP) for recurrence of breast cancer].
    Iba T; Yagi Y; Kidokoro A; Fukunaga M; Momose F
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):83-6. PubMed ID: 7826082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial of high-dose mitoxantrone plus cyclophosphamide and filgrastim in patients with advanced breast carcinoma.
    Sparano JA; Robert N; Silverman P; Lazarus H; Malik U; Venkatraj U; Sarta C
    J Clin Oncol; 1996 Sep; 14(9):2576-83. PubMed ID: 8823338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer].
    Ito Y; Hoshino A; Ohara K; Kamiya O; Nagata K; Kojima T; Kinoshita T; Sugiura I
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1999-2003. PubMed ID: 4051516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer.
    Patrone F; Ballestrero A; Ferrando F; Brema F; Moraglio L; Valbonesi M; Basta P; Ghio R; Gobbi M; Sessarego M
    J Clin Oncol; 1995 Apr; 13(4):840-6. PubMed ID: 7707109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.
    Sonneveld P; de Ridder M; van der Lelie H; Nieuwenhuis K; Schouten H; Mulder A; van Reijswoud I; Hop W; Lowenberg B
    J Clin Oncol; 1995 Oct; 13(10):2530-9. PubMed ID: 7595704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
    Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of mitoxantrone plus cyclophosphamide as first-line treatment of metastatic breast cancer.
    Bezwoda WR; Hesdorffer C
    Cancer; 1986 Oct; 58(8):1621-4. PubMed ID: 3756786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.